Stay updated on Daratumumab for AML/High-Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for AML/High-Risk MDS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.9%
    Check dated 2025-05-07T20:14:54.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.8%
    Check dated 2025-04-30T18:00:03.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2025-04-23T15:35:03.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of a clinical trial study, including the addition of a new principal investigator and collaborators, while significant details about the trial's methodology and treatment have been removed.
    Difference
    46%
    Check dated 2025-04-16T12:44:41.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.6%
    Check dated 2025-04-09T05:48:05.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-04-01T22:44:16.000Z thumbnail image

Stay in the know with updates to Daratumumab for AML/High-Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.